Simon Gebremeskel

1.4k total citations
28 papers, 1.1k citations indexed

About

Simon Gebremeskel is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Simon Gebremeskel has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 12 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Simon Gebremeskel's work include Immune Cell Function and Interaction (6 papers), Virus-based gene therapy research (5 papers) and CAR-T cell therapy research (5 papers). Simon Gebremeskel is often cited by papers focused on Immune Cell Function and Interaction (6 papers), Virus-based gene therapy research (5 papers) and CAR-T cell therapy research (5 papers). Simon Gebremeskel collaborates with scholars based in Canada, United States and Australia. Simon Gebremeskel's co-authors include Brent Johnston, Michael Bezuhly, Robert Liwski, Terry L. LeVatte, Alison J. Gareau, Joshua A. Gillis, Kyle D. Phipps, Paul Hong, Wouter Korver and Julia Schanin and has published in prestigious journals such as Blood, Gastroenterology and Oncogene.

In The Last Decade

Simon Gebremeskel

28 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Gebremeskel Canada 20 439 382 246 132 107 28 1.1k
Maria De Pizzol Italy 12 723 1.6× 368 1.0× 434 1.8× 142 1.1× 97 0.9× 12 1.3k
Е. Р. Черных Russia 18 521 1.2× 251 0.7× 281 1.1× 112 0.8× 200 1.9× 161 1.2k
Pierre Cunin United States 15 432 1.0× 176 0.5× 219 0.9× 161 1.2× 59 0.6× 21 888
Dapeng Wang United States 19 571 1.3× 288 0.8× 494 2.0× 241 1.8× 220 2.1× 44 1.4k
María Casanova-Acebes Spain 11 774 1.8× 305 0.8× 358 1.5× 125 0.9× 61 0.6× 13 1.2k
Adam P. Cribbs United Kingdom 20 460 1.0× 189 0.5× 687 2.8× 87 0.7× 73 0.7× 58 1.4k
Jianmei W. Leavenworth United States 23 825 1.9× 344 0.9× 413 1.7× 60 0.5× 105 1.0× 52 1.5k
Bianling Liu United States 8 671 1.5× 463 1.2× 370 1.5× 62 0.5× 75 0.7× 11 1.2k
Francisco Caiado Portugal 17 298 0.7× 206 0.5× 501 2.0× 273 2.1× 148 1.4× 27 1.0k
Dennis C. Otero United States 18 938 2.1× 416 1.1× 538 2.2× 72 0.5× 69 0.6× 27 1.6k

Countries citing papers authored by Simon Gebremeskel

Since Specialization
Citations

This map shows the geographic impact of Simon Gebremeskel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Gebremeskel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Gebremeskel more than expected).

Fields of papers citing papers by Simon Gebremeskel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Gebremeskel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Gebremeskel. The network helps show where Simon Gebremeskel may publish in the future.

Co-authorship network of co-authors of Simon Gebremeskel

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Gebremeskel. A scholar is included among the top collaborators of Simon Gebremeskel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Gebremeskel. Simon Gebremeskel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McMullen, Nichole, Simon Gebremeskel, Roberto de Antueno, et al.. (2024). Fusogenic vesicular stomatitis virus combined with natural killer T cell immunotherapy controls metastatic breast cancer. Breast Cancer Research. 26(1). 78–78. 4 indexed citations
2.
Korver, Wouter, Simon Gebremeskel, Gian Luca Negri, et al.. (2022). The Inhibitory Receptor Siglec-8 Interacts With FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation. Frontiers in Immunology. 13. 833728–833728. 27 indexed citations
3.
Gebremeskel, Simon, Julia Schanin, Krysta M. Coyle, et al.. (2021). Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody. Frontiers in Immunology. 12. 650331–650331. 86 indexed citations
4.
Liu, Jinghua, Simon Gebremeskel, Chi Yan, et al.. (2020). Myeloid-derived suppressor cell depletion therapy targets IL-17A-expressing mammary carcinomas. Scientific Reports. 10(1). 13343–13343. 26 indexed citations
5.
Schanin, Julia, Simon Gebremeskel, Wouter Korver, et al.. (2020). A monoclonal antibody to Siglec-8 suppresses non-allergic airway inflammation and inhibits IgE-independent mast cell activation. Mucosal Immunology. 14(2). 366–376. 60 indexed citations
6.
Gareau, Alison J., et al.. (2018). Ticagrelor inhibits platelet–tumor cell interactions and metastasis in human and murine breast cancer. Clinical & Experimental Metastasis. 35(1-2). 25–35. 74 indexed citations
7.
Gebremeskel, Simon, et al.. (2018). Promotion of Primary Murine Breast Cancer Growth and Metastasis by Adipose-Derived Stem Cells Is Reduced in the Presence of Autologous Fat Graft. Plastic & Reconstructive Surgery. 143(1). 137–147. 16 indexed citations
8.
Gebremeskel, Simon, et al.. (2017). Natural Killer T-cell Immunotherapy in Combination with Chemotherapy-Induced Immunogenic Cell Death Targets Metastatic Breast Cancer. Cancer Immunology Research. 5(12). 1086–1097. 50 indexed citations
9.
Bœuf, Fabrice Le, Simon Gebremeskel, Nichole McMullen, et al.. (2017). Reovirus FAST Protein Enhances Vesicular Stomatitis Virus Oncolytic Virotherapy in Primary and Metastatic Tumor Models. Molecular Therapy — Oncolytics. 6. 80–89. 39 indexed citations
10.
Corkery, Dale, Simon Gebremeskel, Jayme Salsman, et al.. (2017). Loss of PRP4K drives anoikis resistance in part by dysregulation of epidermal growth factor receptor endosomal trafficking. Oncogene. 37(2). 174–184. 21 indexed citations
11.
Szczesniak, Anna-Maria, James Thomas Toguri, Simon Gebremeskel, et al.. (2016). Cannabinoid 2 receptor is a novel anti-inflammatory target in experimental proliferative vitreoretinopathy. Neuropharmacology. 113(Pt B). 627–638. 27 indexed citations
12.
Gebremeskel, Simon, et al.. (2016). CXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFNγ production and tumor control. OncoImmunology. 5(6). e1160979–e1160979. 30 indexed citations
13.
Gebremeskel, Simon, et al.. (2015). Natural killer T cell activation overcomes immunosuppression to enhance clearance of postsurgical breast cancer metastasis in mice. OncoImmunology. 4(3). e995562–e995562. 60 indexed citations
14.
Phipps, Kyle D., Simon Gebremeskel, Joshua A. Gillis, et al.. (2015). Alternatively Activated M2 Macrophages Improve Autologous Fat Graft Survival in a Mouse Model through Induction of Angiogenesis. Plastic & Reconstructive Surgery. 135(1). 140–149. 63 indexed citations
15.
Gillis, Joshua A., Simon Gebremeskel, Kyle D. Phipps, et al.. (2015). Effect of N-Acetylcysteine on Adipose-Derived Stem Cell and Autologous Fat Graft Survival in a Mouse Model. Plastic & Reconstructive Surgery. 136(2). 179e–188e. 26 indexed citations
16.
Gebremeskel, Simon & Brent Johnston. (2015). Concepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapies. Oncotarget. 6(39). 41600–41619. 101 indexed citations
17.
Gebremeskel, Simon, et al.. (2015). Reconstitution models to evaluate natural killer T cell function in tumor control. Immunology and Cell Biology. 94(1). 90–100. 8 indexed citations
18.
Qiu, Wei, Robert Lam, Oleksandr Voytyuk, et al.. (2014). Insights into the binding of PARP inhibitors to the catalytic domain of human tankyrase-2. Acta Crystallographica Section D Biological Crystallography. 70(10). 2740–2753. 27 indexed citations
19.
Gebremeskel, Simon, Terry L. LeVatte, Robert Liwski, Brent Johnston, & Michael Bezuhly. (2014). The reversible P2Y12 inhibitor ticagrelor inhibits metastasis and improves survival in mouse models of cancer. International Journal of Cancer. 136(1). 234–240. 100 indexed citations
20.
Gillis, Joshua A., Simon Gebremeskel, Kyle D. Phipps, et al.. (2014). N-Acetylcysteine (NAC) Improves Free Autologous Fat Graft Survival. Plastic & Reconstructive Surgery. 134. 70–71. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria De Pizzol Breakdown of academic impact, for papers by Е. Р. Черных Breakdown of academic impact, for papers by Pierre Cunin Breakdown of academic impact, for papers by Dapeng Wang Breakdown of academic impact, for papers by María Casanova-Acebes Breakdown of academic impact, for papers by Adam P. Cribbs Breakdown of academic impact, for papers by Jianmei W. Leavenworth Breakdown of academic impact, for papers by Bianling Liu Breakdown of academic impact, for papers by Francisco Caiado Breakdown of academic impact, for papers by Dennis C. Otero
Rankless by CCL
2026